Inventor · disambiguated record
Qing Xu
Also filed as: XU QING · Xu qing wen
97 granted patents·42 pending applications·643 citations·filing 1999–2025
99Inventor score
Files withGLOBAL BLOOD THERAPEUTICS INC33PORTOLA PHARM INC17XU QING11UNIV GUANGDONG OCEAN7GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP LTD5
Top patents by PatentIndex Score
139 records- 0198US10450269B1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Oct 22, 2019·26 cites·14 claims
- 0298US9776960B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Oct 3, 2017·44 cites·15 claims
- 0397US9458139B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Oct 4, 2016·45 cites·24 claims
- 0497US8952171B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Feb 10, 2015·52 cites·19 claims
- 0597US8138339B2Inhibitors of protein kinasesBAUER SHAWN M·Filed 2009·Granted Mar 20, 2012·63 cites·19 claims
- 0696US9604999B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Granted Mar 28, 2017·45 cites·3 claims
- 0795US11584751B1Substituted imidazoles as GLP-1 receptor agonistsECCOGENE SHANGHAI CO LTD·Filed 2021·Granted Feb 21, 2023·14 cites·25 claims
- 0895US10315991B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2017·Granted Jun 11, 2019·14 cites·3 claims
- 0995US8258144B2Inhibitors of protein kinasesSONG YONGHONG·Filed 2009·Granted Sep 4, 2012·37 cites·19 claims
- 1094US10435393B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2015·Granted Oct 8, 2019·14 cites·11 claims
- 1194US8501944B2Inhibitors of protein kinasesBAUER SHAWN M·Filed 2012·Granted Aug 6, 2013·19 cites·2 claims
- 1294US8349860B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2011·Granted Jan 8, 2013·9 cites·2 claims
- 1394US8318755B2Inhibitors of SYK and JAK protein kinasesJIA ZHAOZHONG J·Filed 2011·Granted Nov 27, 2012·10 cites·2 claims
- 1494US8063058B2Inhibitors of syk and JAK protein kinasesJIA ZHAOZHONG J·Filed 2009·Granted Nov 22, 2011·14 cites·17 claims
- 1593US9981939B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted May 29, 2018·17 cites·7 claims
- 1692US10100040B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Oct 16, 2018·18 cites·21 claims
- 1792US8952027B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2012·Granted Feb 10, 2015·6 cites·21 claims
- 1892US8853230B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2012·Granted Oct 7, 2014·19 cites·14 claims
- 1992US7705004B2Protein kinase inhibitorsPORTOLA PHARM INC·Filed 2008·Granted Apr 27, 2010·22 cites·17 claims
- 2090US10266551B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Granted Apr 23, 2019·16 cites·21 claims
- 2189US11746100B2Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2021·Granted Sep 5, 2023·2 cites·48 claims
- 2288US10533001B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2017·Granted Jan 14, 2020·4 cites·13 claims
- 2388US8367689B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2010·Granted Feb 5, 2013·11 cites·27 claims
- 2484US8846928B2Benzamides and nicotinamides as Syk modulatorsJIA ZHAOZHONG J·Filed 2011·Granted Sep 30, 2014·7 cites·26 claims
- 2583US9359375B2Benzamides and nicotinamides as Syk modulatorsPORTOLA PHARM INC·Filed 2014·Granted Jun 7, 2016·5 cites·15 claims
- 2681US10927365B2Manipulating the circadian clock to increase gene expressionUNIV VANDERBILT·Filed 2015·Granted Feb 23, 2021·2 cites·13 claims
- 2781US9102625B2Nicotinamides as JAK kinase modulatorsBAUER SHAWN M·Filed 2011·Granted Aug 11, 2015·5 cites·10 claims
- 2880US11014884B2Modulators of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·2 cites·60 claims
- 2979US11414410B2Inhibitors of protein kinasesALEXION PHARMA INC·Filed 2019·Granted Aug 16, 2022·0 cites·6 claims
- 3079USD869182SMassage chairSHANGHAI RONGTAI HEALTH TECH CORP LTD·Filed 2018·Granted Dec 10, 2019·19 cites·1 claims
- 3179US2023322704A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3278US2025109122A1Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3378US2025372631A1Secondary battery and electronic deviceNINGDE AMPEREX TECHNOLOGY LTD·Filed 2025·Application pending·0 cites
- 3476US9533986B2Bicyclic dihydropyridone kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Jan 3, 2017·3 cites·18 claims
- 3576US9469654B2Bicyclic oxa-lactam kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Oct 18, 2016·3 cites·20 claims
- 3676US2025140922A1Electrolyte solution, lithium-ion battery, and electronic deviceNINGDE AMPEREX TECHNOLOGY LTD·Filed 2024·Application pending·0 cites
- 3775US12202817B2Cycloalkyl pyrimidines as ferroportin inhibitorsGLOBAL BLOOD THERAPEUTICS INC·Filed 2023·Granted Jan 21, 2025·0 cites·27 claims
- 3875US11530191B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·0 cites·4 claims
- 3975US9139581B2Inhibitors of protein kinasesSONG YONGHONG·Filed 2012·Granted Sep 22, 2015·2 cites·10 claims
- 4074US11286243B2Ferroportin inhibitors and methods of useGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Mar 29, 2022·1 cites·24 claims
- 4174US2022402940A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4272US11964942B2SSAO inhibitors and use thereofECCOGENE SHANGHAI CO LTD·Filed 2022·Granted Apr 23, 2024·0 cites·21 claims
- 4372US11858892B2Adsorbent for removing methanol or CO2 from a hydrocarbon streamUOP LLC·Filed 2022·Granted Jan 2, 2024·0 cites·18 claims
- 4472US10610234B2Open-close-repeatable rotatable hemoclip for the gastrointestinal tract with electrocoagulationZHEJIANG CHUANGXIANG MEDICAL TECH CO LTD·Filed 2017·Granted Apr 7, 2020·3 cites·7 claims
- 4570US11472769B2SSAO inhibitors and use thereofECCOGENE SHANGHAI CO LTD·Filed 2020·Granted Oct 18, 2022·0 cites·22 claims
- 4670US10858317B2Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2019·Granted Dec 8, 2020·0 cites·7 claims
- 4770US9579320B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2014·Granted Feb 28, 2017·0 cites·3 claims
- 4870US2022119407A1Compounds and uses thereof for the modulation of hemoglobinGLOBAL BLOOD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4969US12283354B2Method for estimating effective prestress and calculating evaluation characteristic value of concrete structureCENTRAL RES INSTITUTE OF BUILDING AND CONSTRUCTION CO LTD MCC·Filed 2024·Granted Apr 22, 2025·0 cites·8 claims
- 5069US2025247944A1Drive module for electric motorZAHNRADFABRIK FRIEDRICHSHAFEN·Filed 2025·Application pending·0 cites
Showing the top 50 of 139 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Qing Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →